Acquiring Company
Johnson & Johnson
Acquired Company
Ollin Biosciences
Description
Johnson & Johnson has entered into a definitive agreement to acquire Ollin Biosciences, Inc. for $2.2 billion upfront, plus potential regulatory and commercial milestone payments. Ollin is a clinical-stage company developing therapies for serious eye diseases. Johnson & Johnson will also enter a separate development funding agreement with Blackstone Life Sciences.
Quick answer
Johnson & Johnson is acquiring Ollin Biosciences for $2.2 billion, announced November 16, 2026. Johnson & Johnson is based in New Brunswick, New Jersey, United States.
- How much did Johnson & Johnson pay for Ollin Biosciences?
- The reported deal value is $2.2 billion.
- What does Johnson & Johnson do?
- For over 130 years, Johnson & Johnson has maintained a tradition of quality and innovation.
- Where are Johnson & Johnson and Ollin Biosciences based?
- Johnson & Johnson is based in New Brunswick, New Jersey, United States.
- Who are the decision-makers at Johnson & Johnson?
- Fundz holds 1 contact at Johnson & Johnson. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in hospital & health care and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Nuformix proposes merger with Biovara (November 11, 2026)
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Acrivon Therapeutics Acquires Aqilion’s Drug Development Programs (November 6, 2026)
- Lineage acquires NeuroAirmid Therapeutics (November 12, 2026)
- BioAdaptives, Inc. to acquire Xycota Biosciences LLC to Expand Biotechnology Portfolio (November 4, 2026)
- Biossil Labs Inc. Acquires SYN-004 and Related Assets from Theriva Biologics, Inc. (November 2, 2026)
Who to call at Johnson & Johnson, and when
When Johnson & Johnson changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Johnson & Johnson raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Johnson & Johnson, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Johnson & Johnson. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Johnson & Johnson makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Ollin Biosciences?
Ollin Biosciences was acquired by Johnson & Johnson, based in New Brunswick. The deal was reported on November 16, 2026. For over 130 years, Johnson & Johnson has maintained a tradition of quality and innovation. Learn about the products, people and history that make up our company. Johnson & Johnson is publicly traded (JNJ) and operates in hospital & health care.
When did Johnson & Johnson acquire Ollin Biosciences?
Johnson & Johnson's acquisition of Ollin Biosciences was reported on November 16, 2026. Johnson & Johnson has entered into a definitive agreement to acquire Ollin Biosciences, Inc. for $2.2 billion upfront, plus potential regulatory and commercial milestone payments. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Ollin Biosciences do?
Ollin Biosciences is a startup focused on developing treatments for eye diseases. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.